HEADER TRANSFERASE 30-NOV-22 8HLJ TITLE MUTATED HUMAN ADP-RIBOSYLTRANSFERASE 2 (PARP2) CATALYTIC DOMAIN BOUND TITLE 2 TO OLAPARIB (AZD2281) COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PARP-2,HPARP-2,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE COMPND 5 2,ARTD2,DNA ADP-RIBOSYLTRANSFERASE PARP2,NAD(+) ADP- COMPND 6 RIBOSYLTRANSFERASE 2,ADPRT-2,POLY[ADP-RIBOSE] SYNTHASE 2,PADPRT-2, COMPND 7 PROTEIN POLY-ADP-RIBOSYLTRANSFERASE PARP2; COMPND 8 EC: 2.4.2.30,2.4.2.-; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP2, ADPRT2, ADPRTL2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS DNA ADP-RIBOSYLTRANSFERASE 2, PARP2, OLAPARIB, AZD2281, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR X.Y.WANG,J.ZHOU,B.L.XU REVDAT 2 14-MAY-25 8HLJ 1 JRNL REVDAT 1 01-MAY-24 8HLJ 0 JRNL AUTH X.WANG,J.ZHOU,B.XU JRNL TITL ENGAGING AN ENGINEERED PARP-2 CATALYTIC DOMAIN MUTANT TO JRNL TITL 2 SOLVE THE COMPLEX STRUCTURES HARBORING APPROVED DRUGS FOR JRNL TITL 3 STRUCTURE ANALYSES. JRNL REF BIOORG.CHEM. V. 160 08471 2025 JRNL REFN ISSN 0045-2068 JRNL PMID 40228437 JRNL DOI 10.1016/J.BIOORG.2025.108471 REMARK 2 REMARK 2 RESOLUTION. 2.24 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.24 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.91 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 31971 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.810 REMARK 3 FREE R VALUE TEST SET COUNT : 1538 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.9100 - 4.9800 0.99 2812 153 0.1641 0.1896 REMARK 3 2 4.9800 - 3.9500 1.00 2799 146 0.1545 0.1891 REMARK 3 3 3.9500 - 3.4500 1.00 2788 140 0.1731 0.2124 REMARK 3 4 3.4500 - 3.1400 1.00 2752 149 0.2099 0.2577 REMARK 3 5 3.1400 - 2.9100 1.00 2787 137 0.2243 0.3240 REMARK 3 6 2.9100 - 2.7400 1.00 2766 143 0.2404 0.2911 REMARK 3 7 2.7400 - 2.6000 1.00 2811 116 0.2469 0.3212 REMARK 3 8 2.6000 - 2.4900 1.00 2803 131 0.2546 0.3064 REMARK 3 9 2.4900 - 2.3900 1.00 2739 139 0.2713 0.3319 REMARK 3 10 2.3900 - 2.3100 1.00 2763 156 0.2784 0.3753 REMARK 3 11 2.3100 - 2.2400 0.94 2613 128 0.2777 0.3399 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.290 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.788 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 36.18 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 5762 REMARK 3 ANGLE : 0.745 7783 REMARK 3 CHIRALITY : 0.045 842 REMARK 3 PLANARITY : 0.005 1001 REMARK 3 DIHEDRAL : 18.763 2188 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8HLJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 08-DEC-22. REMARK 100 THE DEPOSITION ID IS D_1300033821. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-MAY-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL02U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979183 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31971 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.240 REMARK 200 RESOLUTION RANGE LOW (A) : 47.910 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.9300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.24 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: ALPHAFOLD MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG-3350, 0.1 M TRIS-HCL PH 8.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 296.5K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 43.14400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 229 REMARK 465 LEU A 580 REMARK 465 GLN A 581 REMARK 465 GLN B 581 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 351 -160.32 -104.07 REMARK 500 GLN A 352 -128.61 -118.68 REMARK 500 HIS A 394 62.41 -108.15 REMARK 500 LYS A 480 71.76 -115.23 REMARK 500 ASN A 502 100.96 -166.73 REMARK 500 GLN A 510 71.21 29.96 REMARK 500 VAL A 529 -168.79 -128.67 REMARK 500 LEU A 538 -161.70 -73.10 REMARK 500 ARG A 570 -51.90 -128.10 REMARK 500 ASN B 247 98.72 -69.70 REMARK 500 ARG B 322 -38.43 -134.44 REMARK 500 ARG B 351 -99.50 -74.80 REMARK 500 GLN B 352 -151.93 -174.00 REMARK 500 HIS B 394 65.26 -112.45 REMARK 500 ARG B 417 84.64 -69.27 REMARK 500 LYS B 480 77.96 -104.36 REMARK 500 ASN B 502 98.92 -163.19 REMARK 500 GLN B 510 39.36 31.63 REMARK 500 PRO B 537 72.30 -69.91 REMARK 500 THR B 544 54.34 -94.98 REMARK 500 PRO B 549 49.67 -73.21 REMARK 500 ASP B 550 -87.70 -119.52 REMARK 500 REMARK 500 REMARK: NULL DBREF 8HLJ A 230 581 UNP Q9UGN5 PARP2_HUMAN 230 581 DBREF 8HLJ B 230 581 UNP Q9UGN5 PARP2_HUMAN 230 581 SEQADV 8HLJ GLY A 229 UNP Q9UGN5 EXPRESSION TAG SEQADV 8HLJ SER A 349 UNP Q9UGN5 THR 349 ENGINEERED MUTATION SEQADV 8HLJ ARG A 351 UNP Q9UGN5 LEU 351 ENGINEERED MUTATION SEQADV 8HLJ GLY A 353 UNP Q9UGN5 SER 353 ENGINEERED MUTATION SEQADV 8HLJ LEU A 354 UNP Q9UGN5 PRO 354 ENGINEERED MUTATION SEQADV 8HLJ GLY B 229 UNP Q9UGN5 EXPRESSION TAG SEQADV 8HLJ SER B 349 UNP Q9UGN5 THR 349 ENGINEERED MUTATION SEQADV 8HLJ ARG B 351 UNP Q9UGN5 LEU 351 ENGINEERED MUTATION SEQADV 8HLJ GLY B 353 UNP Q9UGN5 SER 353 ENGINEERED MUTATION SEQADV 8HLJ LEU B 354 UNP Q9UGN5 PRO 354 ENGINEERED MUTATION SEQRES 1 A 353 GLY PRO GLU SER GLN LEU ASP LEU ARG VAL GLN GLU LEU SEQRES 2 A 353 ILE LYS LEU ILE CYS ASN VAL GLN ALA MET GLU GLU MET SEQRES 3 A 353 MET MET GLU MET LYS TYR ASN THR LYS LYS ALA PRO LEU SEQRES 4 A 353 GLY LYS LEU THR VAL ALA GLN ILE LYS ALA GLY TYR GLN SEQRES 5 A 353 SER LEU LYS LYS ILE GLU ASP CYS ILE ARG ALA GLY GLN SEQRES 6 A 353 HIS GLY ARG ALA LEU MET GLU ALA CYS ASN GLU PHE TYR SEQRES 7 A 353 THR ARG ILE PRO HIS ASP PHE GLY LEU ARG THR PRO PRO SEQRES 8 A 353 LEU ILE ARG THR GLN LYS GLU LEU SER GLU LYS ILE GLN SEQRES 9 A 353 LEU LEU GLU ALA LEU GLY ASP ILE GLU ILE ALA ILE LYS SEQRES 10 A 353 LEU VAL LYS SER GLU ARG GLN GLY LEU GLU HIS PRO LEU SEQRES 11 A 353 ASP GLN HIS TYR ARG ASN LEU HIS CYS ALA LEU ARG PRO SEQRES 12 A 353 LEU ASP HIS GLU SER TYR GLU PHE LYS VAL ILE SER GLN SEQRES 13 A 353 TYR LEU GLN SER THR HIS ALA PRO THR HIS SER ASP TYR SEQRES 14 A 353 THR MET THR LEU LEU ASP LEU PHE GLU VAL GLU LYS ASP SEQRES 15 A 353 GLY GLU LYS GLU ALA PHE ARG GLU ASP LEU HIS ASN ARG SEQRES 16 A 353 MET LEU LEU TRP HIS GLY SER ARG MET SER ASN TRP VAL SEQRES 17 A 353 GLY ILE LEU SER HIS GLY LEU ARG ILE ALA PRO PRO GLU SEQRES 18 A 353 ALA PRO ILE THR GLY TYR MET PHE GLY LYS GLY ILE TYR SEQRES 19 A 353 PHE ALA ASP MET SER SER LYS SER ALA ASN TYR CYS PHE SEQRES 20 A 353 ALA SER ARG LEU LYS ASN THR GLY LEU LEU LEU LEU SER SEQRES 21 A 353 GLU VAL ALA LEU GLY GLN CYS ASN GLU LEU LEU GLU ALA SEQRES 22 A 353 ASN PRO LYS ALA GLU GLY LEU LEU GLN GLY LYS HIS SER SEQRES 23 A 353 THR LYS GLY LEU GLY LYS MET ALA PRO SER SER ALA HIS SEQRES 24 A 353 PHE VAL THR LEU ASN GLY SER THR VAL PRO LEU GLY PRO SEQRES 25 A 353 ALA SER ASP THR GLY ILE LEU ASN PRO ASP GLY TYR THR SEQRES 26 A 353 LEU ASN TYR ASN GLU TYR ILE VAL TYR ASN PRO ASN GLN SEQRES 27 A 353 VAL ARG MET ARG TYR LEU LEU LYS VAL GLN PHE ASN PHE SEQRES 28 A 353 LEU GLN SEQRES 1 B 353 GLY PRO GLU SER GLN LEU ASP LEU ARG VAL GLN GLU LEU SEQRES 2 B 353 ILE LYS LEU ILE CYS ASN VAL GLN ALA MET GLU GLU MET SEQRES 3 B 353 MET MET GLU MET LYS TYR ASN THR LYS LYS ALA PRO LEU SEQRES 4 B 353 GLY LYS LEU THR VAL ALA GLN ILE LYS ALA GLY TYR GLN SEQRES 5 B 353 SER LEU LYS LYS ILE GLU ASP CYS ILE ARG ALA GLY GLN SEQRES 6 B 353 HIS GLY ARG ALA LEU MET GLU ALA CYS ASN GLU PHE TYR SEQRES 7 B 353 THR ARG ILE PRO HIS ASP PHE GLY LEU ARG THR PRO PRO SEQRES 8 B 353 LEU ILE ARG THR GLN LYS GLU LEU SER GLU LYS ILE GLN SEQRES 9 B 353 LEU LEU GLU ALA LEU GLY ASP ILE GLU ILE ALA ILE LYS SEQRES 10 B 353 LEU VAL LYS SER GLU ARG GLN GLY LEU GLU HIS PRO LEU SEQRES 11 B 353 ASP GLN HIS TYR ARG ASN LEU HIS CYS ALA LEU ARG PRO SEQRES 12 B 353 LEU ASP HIS GLU SER TYR GLU PHE LYS VAL ILE SER GLN SEQRES 13 B 353 TYR LEU GLN SER THR HIS ALA PRO THR HIS SER ASP TYR SEQRES 14 B 353 THR MET THR LEU LEU ASP LEU PHE GLU VAL GLU LYS ASP SEQRES 15 B 353 GLY GLU LYS GLU ALA PHE ARG GLU ASP LEU HIS ASN ARG SEQRES 16 B 353 MET LEU LEU TRP HIS GLY SER ARG MET SER ASN TRP VAL SEQRES 17 B 353 GLY ILE LEU SER HIS GLY LEU ARG ILE ALA PRO PRO GLU SEQRES 18 B 353 ALA PRO ILE THR GLY TYR MET PHE GLY LYS GLY ILE TYR SEQRES 19 B 353 PHE ALA ASP MET SER SER LYS SER ALA ASN TYR CYS PHE SEQRES 20 B 353 ALA SER ARG LEU LYS ASN THR GLY LEU LEU LEU LEU SER SEQRES 21 B 353 GLU VAL ALA LEU GLY GLN CYS ASN GLU LEU LEU GLU ALA SEQRES 22 B 353 ASN PRO LYS ALA GLU GLY LEU LEU GLN GLY LYS HIS SER SEQRES 23 B 353 THR LYS GLY LEU GLY LYS MET ALA PRO SER SER ALA HIS SEQRES 24 B 353 PHE VAL THR LEU ASN GLY SER THR VAL PRO LEU GLY PRO SEQRES 25 B 353 ALA SER ASP THR GLY ILE LEU ASN PRO ASP GLY TYR THR SEQRES 26 B 353 LEU ASN TYR ASN GLU TYR ILE VAL TYR ASN PRO ASN GLN SEQRES 27 B 353 VAL ARG MET ARG TYR LEU LEU LYS VAL GLN PHE ASN PHE SEQRES 28 B 353 LEU GLN HET 09L A 601 32 HET 09L B 601 32 HETNAM 09L 4-(3-{[4-(CYCLOPROPYLCARBONYL)PIPERAZIN-1-YL]CARBONYL}- HETNAM 2 09L 4-FLUOROBENZYL)PHTHALAZIN-1(2H)-ONE HETSYN 09L OLAPARIB FORMUL 3 09L 2(C24 H23 F N4 O3) FORMUL 5 HOH *183(H2 O) HELIX 1 AA1 ASP A 235 CYS A 246 1 12 HELIX 2 AA2 ASN A 247 MET A 258 1 12 HELIX 3 AA3 PRO A 266 LEU A 270 5 5 HELIX 4 AA4 THR A 271 ALA A 291 1 21 HELIX 5 AA5 GLY A 295 ILE A 309 1 15 HELIX 6 AA6 THR A 323 SER A 349 1 27 HELIX 7 AA7 HIS A 356 HIS A 366 1 11 HELIX 8 AA8 SER A 376 THR A 389 1 14 HELIX 9 AA9 GLY A 411 PHE A 416 1 6 HELIX 10 AB1 ARG A 431 SER A 433 5 3 HELIX 11 AB2 ASN A 434 GLY A 442 1 9 HELIX 12 AB3 PRO A 451 TYR A 455 5 5 HELIX 13 AB4 MET A 466 ASN A 472 1 7 HELIX 14 AB5 TYR A 473 PHE A 475 5 3 HELIX 15 AB6 ASN A 563 ASN A 565 5 3 HELIX 16 AB7 ASP B 235 CYS B 246 1 12 HELIX 17 AB8 ASN B 247 MET B 258 1 12 HELIX 18 AB9 PRO B 266 LEU B 270 5 5 HELIX 19 AC1 THR B 271 ALA B 291 1 21 HELIX 20 AC2 GLY B 295 ILE B 309 1 15 HELIX 21 AC3 THR B 323 SER B 349 1 27 HELIX 22 AC4 HIS B 356 HIS B 366 1 11 HELIX 23 AC5 SER B 376 THR B 389 1 14 HELIX 24 AC6 GLY B 411 PHE B 416 1 6 HELIX 25 AC7 ARG B 431 SER B 433 5 3 HELIX 26 AC8 ASN B 434 GLY B 442 1 9 HELIX 27 AC9 PRO B 451 TYR B 455 5 5 HELIX 28 AD1 MET B 466 ASN B 472 1 7 HELIX 29 AD2 TYR B 473 PHE B 475 5 3 HELIX 30 AD3 LYS B 504 LEU B 509 5 6 HELIX 31 AD4 SER B 525 PHE B 528 5 4 HELIX 32 AD5 ASN B 563 ASN B 565 5 3 SHEET 1 AA1 5 CYS A 367 PRO A 371 0 SHEET 2 AA1 5 THR A 398 LYS A 409 -1 O GLU A 406 N ARG A 370 SHEET 3 AA1 5 VAL A 567 ASN A 578 -1 O ARG A 570 N VAL A 407 SHEET 4 AA1 5 THR A 482 ALA A 491 -1 N LEU A 485 O LEU A 573 SHEET 5 AA1 5 ARG A 423 GLY A 429 -1 N HIS A 428 O LEU A 486 SHEET 1 AA2 4 ILE A 461 PHE A 463 0 SHEET 2 AA2 4 GLU A 558 VAL A 561 -1 O VAL A 561 N ILE A 461 SHEET 3 AA2 4 SER A 514 GLY A 517 -1 N GLY A 517 O GLU A 558 SHEET 4 AA2 4 CYS A 495 LEU A 498 1 N ASN A 496 O SER A 514 SHEET 1 AA3 3 ALA A 541 ASP A 543 0 SHEET 2 AA3 3 GLY A 519 PRO A 523 -1 N ALA A 522 O SER A 542 SHEET 3 AA3 3 LEU A 554 TYR A 556 1 O LEU A 554 N LYS A 520 SHEET 1 AA4 2 VAL A 529 LEU A 531 0 SHEET 2 AA4 2 SER A 534 VAL A 536 -1 O SER A 534 N LEU A 531 SHEET 1 AA5 5 CYS B 367 PRO B 371 0 SHEET 2 AA5 5 TYR B 397 LYS B 409 -1 O GLU B 406 N ARG B 370 SHEET 3 AA5 5 VAL B 567 PHE B 579 -1 O ARG B 570 N VAL B 407 SHEET 4 AA5 5 THR B 482 ALA B 491 -1 N LEU B 485 O LEU B 573 SHEET 5 AA5 5 ARG B 423 GLY B 429 -1 N MET B 424 O VAL B 490 SHEET 1 AA6 4 ILE B 461 PHE B 463 0 SHEET 2 AA6 4 GLU B 558 VAL B 561 -1 O TYR B 559 N PHE B 463 SHEET 3 AA6 4 SER B 514 GLY B 517 -1 N THR B 515 O ILE B 560 SHEET 4 AA6 4 CYS B 495 LEU B 498 1 N LEU B 498 O LYS B 516 SHEET 1 AA7 3 ALA B 541 ASP B 543 0 SHEET 2 AA7 3 GLY B 519 PRO B 523 -1 N ALA B 522 O SER B 542 SHEET 3 AA7 3 LEU B 554 TYR B 556 1 O ASN B 555 N MET B 521 SHEET 1 AA8 2 VAL B 529 LEU B 531 0 SHEET 2 AA8 2 SER B 534 VAL B 536 -1 O SER B 534 N LEU B 531 CRYST1 40.902 86.288 95.828 90.00 90.44 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024449 0.000000 0.000188 0.00000 SCALE2 0.000000 0.011589 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010436 0.00000 CONECT 5575 5576 5577 CONECT 5576 5575 5577 CONECT 5577 5575 5576 5578 CONECT 5578 5577 5579 5580 CONECT 5579 5578 CONECT 5580 5578 5581 5583 CONECT 5581 5580 5582 CONECT 5582 5581 5585 CONECT 5583 5580 5584 CONECT 5584 5583 5585 CONECT 5585 5582 5584 5586 CONECT 5586 5585 5587 5588 CONECT 5587 5586 CONECT 5588 5586 5589 5590 CONECT 5589 5588 5594 CONECT 5590 5588 5591 5592 CONECT 5591 5590 CONECT 5592 5590 5593 CONECT 5593 5592 5594 CONECT 5594 5589 5593 5595 CONECT 5595 5594 5596 CONECT 5596 5595 5597 5606 CONECT 5597 5596 5598 5602 CONECT 5598 5597 5599 CONECT 5599 5598 5600 CONECT 5600 5599 5601 CONECT 5601 5600 5602 CONECT 5602 5597 5601 5603 CONECT 5603 5602 5604 5605 CONECT 5604 5603 CONECT 5605 5603 5606 CONECT 5606 5596 5605 CONECT 5607 5608 5609 CONECT 5608 5607 5609 CONECT 5609 5607 5608 5610 CONECT 5610 5609 5611 5612 CONECT 5611 5610 CONECT 5612 5610 5613 5615 CONECT 5613 5612 5614 CONECT 5614 5613 5617 CONECT 5615 5612 5616 CONECT 5616 5615 5617 CONECT 5617 5614 5616 5618 CONECT 5618 5617 5619 5620 CONECT 5619 5618 CONECT 5620 5618 5621 5622 CONECT 5621 5620 5626 CONECT 5622 5620 5623 5624 CONECT 5623 5622 CONECT 5624 5622 5625 CONECT 5625 5624 5626 CONECT 5626 5621 5625 5627 CONECT 5627 5626 5628 CONECT 5628 5627 5629 5638 CONECT 5629 5628 5630 5634 CONECT 5630 5629 5631 CONECT 5631 5630 5632 CONECT 5632 5631 5633 CONECT 5633 5632 5634 CONECT 5634 5629 5633 5635 CONECT 5635 5634 5636 5637 CONECT 5636 5635 CONECT 5637 5635 5638 CONECT 5638 5628 5637 MASTER 246 0 2 32 28 0 0 6 5819 2 64 56 END